INGREDIENT · NEW-AGE
Bifida ferment lysate in skincare: the probiotic extract
Bifida ferment lysate is a probiotic-derived ingredient: the broken-up remains of beneficial bacteria, not live ones. It has one well-known trial in sensitive skin and a field that is still young.
You may see it written as
- Bifida Ferment Lysate
What a lysate is
A lysate is made by breaking open bacteria, so the product contains their parts rather than living cells. A 2010 paper describes a Bifidobacterium longum lysate as a non-replicating bacterial form, tested first on skin samples and nerve cells in the lab and then in a clinical trial.1
A 2025 review of topical probiotics says the field is promising for skin conditions linked to a disturbed skin microbiome, and also that studies are small and varied, with no standard dosing and limited long-term safety data.2
The trial in reactive skin
In the 2010 paper's clinical trial, 66 women with reactive skin were randomised to a cream with 10% of the bacterial extract or a control cream (33 each). They applied it to the face, arms and legs twice a day for two months. Skin sensitivity, tested with a lactic acid stinging test, fell significantly in the extract group, and their skin withstood more tape-strippings before the barrier broke down. Dryness fell after 29 days.1
In the lab part, the extract reduced inflammatory signs in skin samples and reduced release of a pain-related signal from nerve cells.1 The authors speculate that it may reduce skin sensitivity by lowering nerve reactivity.1
It is one trial of 66 women from a research team linked to a manufacturer, published in 2010. We did not find a second independent trial of the lysate in skin.1,2
Where this fits among postbiotics
Bifida ferment lysate belongs to a group called postbiotics, defined as non-living microbial cells and their products. A 2026 review of 16 studies of topical postbiotics reported lower eczema severity scores and itch, better skin barrier function and favourable safety profiles, mainly in atopic dermatitis and acne.3
The review covers postbiotics as a class, not this ingredient on its own, and it found no interventional studies in rosacea.3 Treat it as context for the 66-woman trial above, not as a second trial of the same extract.
Using bifida ferment lysate with other products
The trial compared one cream containing the extract with a control cream.1 We did not find a source on layering it with other products.
Bifida ferment lysate in pregnancy and breastfeeding
We found no pregnancy- or lactation-specific evidence for this ingredient.
Evidence on cosmetic products in pregnancy is limited overall, so ask your doctor or midwife about the specific product you use.4
What you will see on the label
On a label, look for Bifida Ferment Lysate. Snifff shows it as Low risk. For the rest of the formula, see what the score means and how to read the list.
As Snifff shows itBifida Ferment Lysate
Pregnancy and nursing
We found no pregnancy- or lactation-specific evidence for this ingredient.
Wording as it appears in the extension, which can change between releases.
A FEW MORE ANSWERS
Common questions about bifida ferment lysate
What is bifida ferment lysate?
A non-living extract of Bifidobacterium bacteria. A 2010 paper describes it as a non-replicating bacterial form.1
Is bifida ferment lysate good for sensitive skin?
In a trial of 66 women with reactive skin, a cream with 10% of the extract reduced sensitivity and dryness over two months compared with a control cream.1
Is it the same as a probiotic cream?
No. A lysate has no live bacteria.1 A 2025 review covers topical probiotics generally and calls the evidence promising but limited.2
Is bifida ferment lysate safe in pregnancy?
Snifff found no pregnancy-specific evidence for Bifida ferment lysate. Ask your doctor or midwife about the product you use.
WHERE THIS COMES FROM
Sources
- Bifidobacterium longum lysate, a new ingredient for reactive skinGuéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, Breton L, et al. · Experimental Dermatology · 2010
- Topical probiotics as a novel approach in the treatment of chronic dermatoses associated with skin dysbiosis: a narrative reviewNowicka D, Kucharczyk E, Pawłuszkiewicz K, Korgiel M, Busłowicz T, Ponikowska M · International Journal of Molecular Sciences · 2025
- Postbiotics in dermatology: a literature review of emerging topical therapies for acne, rosacea, and eczemaFlores Rodriguez JC, et al. · Cureus · 2026
- Cosmetic dermatology in pregnancy and lactation: a risk-benefit framework for clinical practiceKovacs T, et al. · International Journal of Dermatology · 2026
This page explains an ingredient. It is not medical advice, and it is not an assessment of any product. If you are pregnant, breastfeeding, or have a skin condition, ask your doctor or pharmacist.